These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 15122056

  • 1. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
    [Abstract] [Full Text] [Related]

  • 2. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
    Pawlak K, Pawlak D, Mysliwiec M.
    Cytokine; 2005 Jul 07; 31(1):18-24. PubMed ID: 15896974
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Cytokine; 2004 Dec 21; 28(6):197-204. PubMed ID: 15566948
    [Abstract] [Full Text] [Related]

  • 4. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
    Pawlak K, Pawlak D, Myśliwiec M.
    Pol Arch Med Wewn; 2005 Jan 21; 113(1):21-6. PubMed ID: 16130597
    [Abstract] [Full Text] [Related]

  • 5. Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease.
    Pawlak K, Pawlak D, Mysliwiec M.
    Am J Nephrol; 2004 Jan 21; 24(6):635-40. PubMed ID: 15627719
    [Abstract] [Full Text] [Related]

  • 6. Relations between oxidative stress, hepatocyte growth factor, and liver disease in hemodialysis patients.
    Borawski J, Pawlak K, Naumnik B, Myśliwiec M.
    Ren Fail; 2002 Nov 21; 24(6):825-37. PubMed ID: 12472204
    [Abstract] [Full Text] [Related]

  • 7. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
    Pawlak K, Pawlak D, Myśliwiec M.
    Cytokine; 2006 Sep 21; 35(5-6):258-62. PubMed ID: 17070067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
    Pawlak K, Pawlak D, Mysliwiec M.
    Clin Biochem; 2005 Aug 21; 38(8):700-5. PubMed ID: 15963971
    [Abstract] [Full Text] [Related]

  • 13. Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Am J Nephrol; 2006 Aug 21; 26(5):497-502. PubMed ID: 17119331
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.
    Pawlak K, Mysliwiec M, Pawlak D.
    Thromb Res; 2014 Sep 21; 134(3):711-6. PubMed ID: 25065558
    [Abstract] [Full Text] [Related]

  • 16. Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Haemost; 2004 Sep 21; 92(3):646-53. PubMed ID: 15351863
    [Abstract] [Full Text] [Related]

  • 17. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2007 Sep 21; 120(6):871-6. PubMed ID: 17331567
    [Abstract] [Full Text] [Related]

  • 18. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
    Pawlak K, Mysliwiec M, Pawlak D.
    Life Sci; 2013 Mar 12; 92(4-5):253-8. PubMed ID: 23295961
    [Abstract] [Full Text] [Related]

  • 19. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality.
    Lobo JC, Stockler-Pinto MB, Farage NE, Faulin Tdo E, Abdalla DS, Torres JP, Velarde LG, Mafra D.
    Ren Fail; 2013 Mar 12; 35(5):680-5. PubMed ID: 23650973
    [Abstract] [Full Text] [Related]

  • 20. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, Vlassopoulos D.
    Int J Artif Organs; 2009 Dec 12; 32(12):872-82. PubMed ID: 20037892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.